Your browser doesn't support javascript.
loading
EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.
Wilson, I M; Vucic, E A; Enfield, K S S; Thu, K L; Zhang, Y A; Chari, R; Lockwood, W W; Radulovich, N; Starczynowski, D T; Banáth, J P; Zhang, M; Pusic, A; Fuller, M; Lonergan, K M; Rowbotham, D; Yee, J; English, J C; Buys, T P H; Selamat, S A; Laird-Offringa, I A; Liu, P; Anderson, M; You, M; Tsao, M S; Brown, C J; Bennewith, K L; MacAulay, C E; Karsan, A; Gazdar, A F; Lam, S; Lam, W L.
Afiliación
  • Wilson IM; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Vucic EA; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Enfield KS; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Thu KL; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Zhang YA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Chari R; 1] Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada [2] Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Lockwood WW; 1] Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada [2] National Human Genome Research Institute, Cancer Genetics Branch, Bethesda, MD, USA.
  • Radulovich N; Ontario Cancer Institute/Princess Margaret Hospital, Toronto, ON, Canada.
  • Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, USA.
  • Banáth JP; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Zhang M; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Pusic A; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Fuller M; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Lonergan KM; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Rowbotham D; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Yee J; Department of Surgery, Vancouver General Hospital, Vancouver, BC, Canada.
  • English JC; Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada.
  • Buys TP; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Selamat SA; Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA, USA.
  • Laird-Offringa IA; Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA, USA.
  • Liu P; Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA.
  • Anderson M; Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA.
  • You M; Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA.
  • Tsao MS; Ontario Cancer Institute/Princess Margaret Hospital, Toronto, ON, Canada.
  • Brown CJ; Department of Medical Genetics, University of British Columbia, Life Sciences Centre, Vancouver, BC, Canada.
  • Bennewith KL; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • MacAulay CE; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Karsan A; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Gazdar AF; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Lam S; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Lam WL; Integrative Oncology Genetics Unit, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Oncogene ; 33(36): 4464-73, 2014 Sep 04.
Article en En | MEDLINE | ID: mdl-24096489
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transactivadores / Carcinoma de Pulmón de Células no Pequeñas / Silenciador del Gen / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transactivadores / Carcinoma de Pulmón de Células no Pequeñas / Silenciador del Gen / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido